{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:30:09Z","timestamp":1787506209490,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008781","name":"Pomorski Uniwersytet Medyczny W Szczecinie","doi-asserted-by":"publisher","award":["MB-127-233\/18"],"award-info":[{"award-number":["MB-127-233\/18"]}],"id":[{"id":"10.13039\/501100008781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.taap.2026.117735","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:16:04Z","timestamp":1769213764000},"page":"117735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Expression of drug transporters in human allogenic transplanted kidneys in acute rejection"],"prefix":"10.1016","volume":"508","author":[{"given":"J.","family":"\u0141apczuk-Roma\u0144ska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hybiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Piotrowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Marchelek-My\u015bliwiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Wilk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"S\u0142ojewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Urasi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dro\u017adzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.taap.2026.117735_bb0005","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1002\/1873-3468.13982","article-title":"Mass spectrometry-based abundance atlas of ABC transporters in human liver, gut, kidney, brain and skin","volume":"594","author":"Al-Majdoub","year":"2020","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.taap.2026.117735_bib294","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/toxins14010015","article-title":"The prescription of drugs that inhibit organic anion transporters 1 or 3 is associated with the plasma accumulation of uremic toxins in kidney transplant recipients","volume":"14","author":"Andr\u00e9","year":"2021","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.taap.2026.117735_bb0010","doi-asserted-by":"crossref","first-page":"F165","DOI":"10.1152\/ajprenal.90257.2008","article-title":"Kidney-specific expression of human organic cation transporter 2 (OCT2\/SLC22A2) is regulated by DNA methylation","volume":"295","author":"Aoki","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"8","key":"10.1016\/j.taap.2026.117735_bb0020","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1124\/dmd.119.086579","article-title":"Kidney cortical transporter expression across species using quantitative proteomics","volume":"47","author":"Basit","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2026.117735_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101868","article-title":"Ergothioneine, recent developments","volume":"42","author":"Cheah","year":"2021","journal-title":"Redox Biol."},{"issue":"6","key":"10.1016\/j.taap.2026.117735_bb0030","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1021\/mp4000234","article-title":"Kidney transplantation down-regulates expression of organic cation transporters, which translocate \u03b2-blockers and fluoroquinolones","volume":"10","author":"Ciarimboli","year":"2013","journal-title":"Mol. Pharm."},{"issue":"24","key":"10.1016\/j.taap.2026.117735_bib306","doi-asserted-by":"crossref","first-page":"e3465","DOI":"10.21769\/BioProtoc.3465","article-title":"Semi-quantitative determination of protein expression using immunohistochemistry staining and analysis: an integrated protocol","volume":"9","author":"Crowe","year":"2019","journal-title":"Bio Protoc."},{"issue":"8","key":"10.1016\/j.taap.2026.117735_bb0035","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1158\/0008-5472.CAN-16-2548","article-title":"OCTN1 is a high-affinity carrier of nucleoside analogues","volume":"77","author":"Drenberg","year":"2017","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.taap.2026.117735_bib295","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3390\/biomedicines9040426","article-title":"Membrane carriers and transporters in kidney physiology and disease","volume":"9","author":"Drozdzik","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.taap.2026.117735_bb0040","author":"European Medicines Agency"},{"issue":"5","key":"10.1016\/j.taap.2026.117735_bb0045","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/cpt.1115","article-title":"Disease-associated changes in drug transporters may impact the pharmacokinetics and\/or toxicity of drugs: a white paper from the International Transporter Consortium","volume":"104","author":"Evers","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2026.117735_bb0050","series-title":"In Vitro Metabolism- and Transporter- Mediated Drug-drug Interaction Studies Guidance for Industry","author":"Food and Drug Administration","year":"2017"},{"key":"10.1016\/j.taap.2026.117735_bb0055","doi-asserted-by":"crossref","first-page":"4","DOI":"10.15761\/NRD.1000166","article-title":"Cyclosporine A nephrotoxicity: downregulation of multidrug resistance associated protein 2 (MRP2) by upregulated miRNA133a","volume":"5","author":"Fries","year":"2020","journal-title":"Nephrol. Renal Dis."},{"issue":"12","key":"10.1016\/j.taap.2026.117735_bb0060","doi-asserted-by":"crossref","first-page":"6439","DOI":"10.3390\/ijms22126439","article-title":"In vitro inhibition of renal OCT2 and MATE1 secretion by antiemetic drugs","volume":"22","author":"George","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2026.117735_bib307","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2026.117735_bb0065","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejps.2017.11.001","article-title":"Renal organic anion transporters in drug-drug interactions and diseases","volume":"112","author":"Huo","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"50","key":"10.1016\/j.taap.2026.117735_bb0075","doi-asserted-by":"crossref","first-page":"20206","DOI":"10.1073\/pnas.1319582110","article-title":"ABCC6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release","volume":"110","author":"Jansen","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.taap.2026.117735_bb0080","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001001","article-title":"Evaluation of renal anionic secretion following living-donor and deceased-donor renal transplantation: a clinical pharmacokinetic study of cefoxitin microdosing","volume":"6","author":"Kalluri","year":"2020","journal-title":"Transplant. Direct"},{"issue":"1","key":"10.1016\/j.taap.2026.117735_bb0085","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1124\/pr.118.015578","article-title":"Organic cation transporters in health and disease","volume":"72","author":"Koepsell","year":"2020","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.taap.2026.117735_bb0090","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1046\/j.1523-1755.2001.00782.x","article-title":"Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients","volume":"60","author":"Koziolek","year":"2001","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.taap.2026.117735_bb0095","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000365014","article-title":"Chronic kidney disease results in deficiency of ABCC6, the novel inhibitor of vascular calcification","volume":"40","author":"Lau","year":"2014","journal-title":"Am. J. Nephrol."},{"issue":"4","key":"10.1016\/j.taap.2026.117735_bb0100","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1517\/17425255.2.4.505","article-title":"Drug-drug interactions involving membrane transporters in the human kidney","volume":"2","author":"Li","year":"2006","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"4","key":"10.1016\/j.taap.2026.117735_bib290","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/1061186X.2019.1678169","article-title":"LPS-induced inflammation delays the transportation of ASP+ due to down-regulation of OCTN1\/2 in alveolar epithelial cells","volume":"28","author":"Li","year":"2020","journal-title":"J. Drug Target"},{"issue":"9","key":"10.1016\/j.taap.2026.117735_bb0105","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1016\/j.xphs.2017.04.078","article-title":"Transporters involved in metformin pharmacokinetics and treatment response","volume":"106","author":"Liang","year":"2017","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.taap.2026.117735_bb0110","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1124\/dmd.106.012112","article-title":"Mechanism of the regulation of organic cation\/carnitine transporter 1 (SLC22A4) by rheumatoid arthritis-associated transcriptional factor RUNX1 and inflammatory cytokines","volume":"35","author":"Maeda","year":"2007","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.taap.2026.117735_bb0115","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1208\/s12248-012-9404-z","article-title":"Regulatory pathways for ATP-binding cassette transport proteins in kidney proximal tubules","volume":"14","author":"Masereeuw","year":"2012","journal-title":"AAPS J."},{"issue":"4","key":"10.1016\/j.taap.2026.117735_bb0120","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1124\/dmd.107.019869","article-title":"Altered pharmacokinetics of cationic drugs caused by down-regulation of renal rat organic cation transporter 2 (Slc22a2) and rat multidrug and toxin extrusion 1 (Slc47a1) in ischemia\/reperfusion-induced acute kidney injury","volume":"36","author":"Matsuzaki","year":"2008","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.taap.2026.117735_bb0125","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/cpt.757","article-title":"The role of the kidney in drug elimination: transport, metabolism, and the impact of kidney disease on drug clearance","volume":"102","author":"Miners","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.taap.2026.117735_bb0130","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1021\/pr070203n","article-title":"In-depth proteomic profiling of the normal human kidney glomerulus using two-dimensional protein prefractionation in combination with liquid chromatography-tandem mass spectrometry","volume":"6","author":"Miyamoto","year":"2007","journal-title":"J. Proteome Res."},{"issue":"5","key":"10.1016\/j.taap.2026.117735_bb0135","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/clpt.2012.44","article-title":"The UCSF-FDA TransPortal: a public drug transporter database","volume":"92","author":"Morrissey","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2026.117735_bb0140","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-pharmtox-011112-140317","article-title":"Renal transporters in drug development","volume":"53","author":"Morrissey","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.taap.2026.117735_bib301","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fphar.2014.00248","article-title":"The role of drug transporters in the kidney: lessons from tenofovir","volume":"5","author":"Moss","year":"2014","journal-title":"Front Pharmacol."},{"issue":"2","key":"10.1016\/j.taap.2026.117735_bb0145","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1208\/s12248-013-9465-7","article-title":"Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney","volume":"15","author":"Motohashi","year":"2013","journal-title":"AAPS J."},{"issue":"4","key":"10.1016\/j.taap.2026.117735_bb0150","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1681\/ASN.V134866","article-title":"Gene expression levels and immunolocalization of organic ion transporters in the human kidney","volume":"13","author":"Motohashi","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.taap.2026.117735_bib296","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1124\/dmd.117.079384","article-title":"Expression of organic anion transporter 1 or 3 in human kidney proximal tubule cells reduces cisplatin sensitivity","volume":"46","author":"Nieskens","year":"2018","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.taap.2026.117735_bib302","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2133\/dmpk.20.452","article-title":"Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies","volume":"20","author":"Nishimura","year":"2005","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"21","key":"10.1016\/j.taap.2026.117735_bib289","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.3390\/ijms20215303","article-title":"Protein abundance of clinically relevant drug transporters in the human kidneys","volume":"20","author":"Oswald","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.taap.2026.117735_bb0180","first-page":"576","article-title":"Identification of a novel human organic cation transporter specific for ergothioneine","volume":"296","author":"Pizzagalli","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.taap.2026.117735_bib287","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3390\/ijms23020914","article-title":"OCTN1: A widely studied but still enigmatic organic cation transporter linked to human pathology and drug interactions","volume":"23","author":"Pochini","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.taap.2026.117735_bib288","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1124\/dmd.116.072066","article-title":"Abundance of drug transporters in the human kidney cortex as quantified by quantitative targeted proteomics","volume":"44","author":"Prasad","year":"2016","journal-title":"Drug Metab. Dispos."},{"issue":"13","key":"10.1016\/j.taap.2026.117735_bb0185","first-page":"4949","article-title":"Role of MATE transporters in regulation of renal and hepatic drug elimination","volume":"21","author":"Radchenko","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.taap.2026.117735_bb0190","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/0192623320937012","article-title":"Kidney transporters and drug-induced injury in drug development","volume":"48","author":"Radi","year":"2020","journal-title":"Toxicol. Pathol."},{"issue":"3","key":"10.1016\/j.taap.2026.117735_bib298","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.pharmthera.2005.07.005","article-title":"Human renal organic anion transporters: characteristics and contributions to drug and drug metabolite excretion","volume":"109","author":"Robertson","year":"2006","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.taap.2026.117735_bib300","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/labinvest.3780444","article-title":"MRP6 (ABCC6) detection in normal human tissues and tumors","volume":"82","author":"Scheffer","year":"2002","journal-title":"Lab. Invest."},{"issue":"10","key":"10.1016\/j.taap.2026.117735_bb0205","first-page":"591","article-title":"The role of organic anion transporters in the kidney","volume":"15","author":"Schnell","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"issue":"9","key":"10.1016\/j.taap.2026.117735_bb0220","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.3390\/ijms22094555","article-title":"ABCC6, pyrophosphate and ectopic calcification: therapeutic solutions","volume":"22","author":"Shimada","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.taap.2026.117735_bib291","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.kint.2017.04.032","article-title":"Impairment of the carnitine\/organic cation transporter 1-ergothioneine axis is mediated by intestinal transporter dysfunction in chronic kidney disease","volume":"92","author":"Shinozaki","year":"2017","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.taap.2026.117735_bib293","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1021\/mp0340082","article-title":"Involvement of OCTN1 (SLC22A4) in pH-dependent transport of organic cations","volume":"1","author":"Tamai","year":"2004","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.taap.2026.117735_bib292","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bcp.2007.04.010","article-title":"Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions\/H(+)-organic cation antiporters","volume":"74","author":"Tanihara","year":"2007","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.taap.2026.117735_bib299","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/03602530500205275","article-title":"Function and regulation of multidrug resistance proteins (MRPs) in the renal elimination of organic anions","volume":"37","author":"van de Water","year":"2005","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.taap.2026.117735_bb0250","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fendo.2018.00155","article-title":"Glucose transporters in diabetic kidney disease-friends or foes?","volume":"9","author":"Wasik","year":"2018","journal-title":"Front. Endocrinol."},{"issue":"7","key":"10.1016\/j.taap.2026.117735_bib297","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/mnfr.201000652","article-title":"Interaction of hydroxycinnamic acids and their conjugates with organic anion transporters and ATP-binding cassette transporters","volume":"55","author":"Wong","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"issue":"10","key":"10.1016\/j.taap.2026.117735_bb0260","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1016\/j.transproceed.2008.06.089","article-title":"Different effect of cyclosporine and tacrolimus on renal expression of P-glycoprotein in human kidney transplantation","volume":"40","author":"Yu","year":"2008","journal-title":"Transplant. Proceed."},{"issue":"2","key":"10.1016\/j.taap.2026.117735_bib286","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0022-3565(24)38199-6","article-title":"Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations","volume":"289","author":"Yabuuchi","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.taap.2026.117735_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066159","article-title":"Podocyte expression of membrane transporters involved in puromycin aminonucleoside-mediated injury","volume":"8","author":"Zennaro","year":"2013","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.taap.2026.117735_bb0275","doi-asserted-by":"crossref","first-page":"21366","DOI":"10.3390\/ijms151121366","article-title":"Small molecule membrane transporters in the mammalian podocyte: a pathogenic and therapeutic target","volume":"15","author":"Zennaro","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2026.117735_bib305","doi-asserted-by":"crossref","first-page":"746208","DOI":"10.3389\/fphar.2021.746208","article-title":"Drug transporters in the kidney: perspectives on species differences, disease status, and molecular docking","volume":"12","author":"Zou","year":"2021","journal-title":"Front Pharmacol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26000311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26000311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:47:53Z","timestamp":1770112073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X26000311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":57,"alternative-id":["S0041008X26000311"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2026.117735","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of drug transporters in human allogenic transplanted kidneys in acute rejection","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2026.117735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117735"}}